JPS61268183A - Dna, recombinant dna and microorganism containing same - Google Patents

Dna, recombinant dna and microorganism containing same

Info

Publication number
JPS61268183A
JPS61268183A JP60110565A JP11056585A JPS61268183A JP S61268183 A JPS61268183 A JP S61268183A JP 60110565 A JP60110565 A JP 60110565A JP 11056585 A JP11056585 A JP 11056585A JP S61268183 A JPS61268183 A JP S61268183A
Authority
JP
Japan
Prior art keywords
dna
bacillus
plasmid
recombinant
recombinant dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60110565A
Other languages
Japanese (ja)
Inventor
Haruhisa Hirata
晴久 平田
Hirosuke Okada
岡田 弘輔
Seiji Negoro
根来 誠司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Priority to JP60110565A priority Critical patent/JPS61268183A/en
Priority to US06/780,842 priority patent/US4861718A/en
Priority to DE198585112245T priority patent/DE176971T1/en
Priority to EP85112245A priority patent/EP0176971A3/en
Publication of JPS61268183A publication Critical patent/JPS61268183A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • C12N9/2471Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PURPOSE:To provide the titled microorganism containing a specific DNA and a recombinant DNA containing the same and suitable for the expression of specific polypeptide. CONSTITUTION:A heat-resistant beta-galactosidase gene [bgaB] cloned to E.coli plasmid pHG1 or B.subtilis plasmid pHG5, etc., is incised with a restriction enzyme to separate a DNA of formula containing the promoter region originated from a thermophilic bacterium, Bacillus stearothermophilus. The DNA is linked to a vector DNA incised with a restriction enzyme (e.g. a plasmid replicable with a Bacillus such as pUB110) using T4DNA ligase to obtain a recombinant DNA integrated with the above DNA. The recombinant DNA is introduced into a bacterial cell of Bacillus genus in a specific medium by a protoplast transformation method.

Description

【発明の詳細な説明】 (発明の目的) 本発明は好熱菌バシルス・ステアロサーモフィルス由来
のプロモーター領域を含むDNA。
Detailed Description of the Invention (Object of the Invention) The present invention provides a DNA containing a promoter region derived from the thermophilic bacterium Bacillus stearothermophilus.

そのDNAを組込んだ組換体DNAおよびそれらを含む
微生物に関するものである。近年遺伝子操作技術の発達
ζ二より、外来遺伝子由来の蛋白質を微生物を用いて大
量生産することが可能になってきている。
This invention relates to recombinant DNA that has incorporated this DNA and microorganisms that contain them. With the recent development of genetic engineering technology, it has become possible to mass-produce proteins derived from foreign genes using microorganisms.

微生物によるこれら蛋白質生産(二関する遺伝子の発現
のためC二は強いプロモーターを用いることが重要な要
素の一つである。
One of the important factors is to use a strong C2 promoter for the expression of genes related to the production of these proteins by microorganisms.

従来、大腸菌を宿主とする系では強いプロモーターを含
む発現ベクターの開発が進み、  trpプロモーター
、  lacプロモーター、  1ppプロモーター、
  phoプロモーター等が利用されている。
Conventionally, expression vectors containing strong promoters have been developed in systems using E. coli as a host, such as trp promoter, lac promoter, 1pp promoter,
The pho promoter etc. are used.

一方、枯草菌に代表されるパシルス属細菌は安全性、蛋
白質の菌体外分泌能等の点で、大腸菌に比べて優れた宿
主であるが2発現ベクターの開発はかなり遅れている。
On the other hand, bacteria of the genus Pacillus, represented by Bacillus subtilis, are superior hosts compared to Escherichia coli in terms of safety, ability to secrete proteins outside the body, etc., but the development of expression vectors is far behind.

従来、バシルス属細菌C;おける発現ベクターの作成と
その利用C二関しては枯草菌のファージspo 2のプ
ロモーターを利用したプラスミドpPL608 (i;
’ −y (Gene)第16巻、199頁、  19
81年、〕。
Conventionally, regarding the construction of an expression vector in Bacillus bacteria and its use, plasmid pPL608 (i;
'-y (Gene) Volume 16, Page 199, 19
1981, ].

枯草菌の染色体DNA上の未同定のプロモーターを利用
したpGR71シリーズのプラスミド〔モレキュラー・
クローニング・アンド・ジーン・レギュレーション・イ
ン・バシリイ(MolecularCloning a
nd Gene Regulation in Bac
illi)、第311頁。
pGR71 series plasmid [Molecular
Cloning and gene regulation in bacteria (Molecular Cloning a
nd Gene Regulation in Bac
illi), page 311.

アカデミツク・プV ス(Academic Pres
s )、 1982年、〕。
Academic Press
s), 1982,].

パシルス・ライヘニホルミスのペニンリナーゼ遺伝子(
pen P)のプロモーターを利用したプラスミド(モ
レキュラー・クローニング・アンド・ジーン・レギュレ
ーション・イン・パシリイ。
Peninlinase gene of Pacillus leicheniformis (
A plasmid (Molecular Cloning and Gene Regulation in PA) using the promoter of penP).

第159頁、アカデミツク・プレス、  1982年)
等があげられるが、いずれもプロモーターの下流(:組
込んだ外来遺伝子の発現量がまだ充分とはいえない。
p. 159, Academic Press, 1982)
etc., but all of them are downstream of the promoter (: the amount of expression of the inserted foreign gene is still not sufficient).

本発明者等は、先C:遺伝子組換え技術を利用してバシ
ルス・ステアロサーモフィルスの耐熱性β−ガラクトシ
ダーゼ遺伝子(bga B )をベクターを介して枯草
菌に導入することに成功し、この枯草菌が細胞蛋白質当
り6〜10%lニーも及ぶ耐熱性β−ガラクトシダーゼ
を生産することを見出した。
The present inventors succeeded in introducing the heat-stable β-galactosidase gene (bga B) of Bacillus stearothermophilus into Bacillus subtilis via a vector using C. genetic recombination technology. It has been found that Bacillus subtilis produces as much as 6-10% of heat-stable β-galactosidase per cell protein.

本発明は、この耐熱性β−ガラクトシダーゼの枯草菌に
おける高発現機構を利用したパシルス属細菌を宿主とす
る発現ベクターの開発を目的とする研究過程(=於いて
好熱菌パシルス・ステアロサーモフィルス由来のプロモ
ーターが強いプロモーター活性を有することを見出し、
そのDNA構造を解明したことに基くものであり。
The present invention is a research process aimed at developing an expression vector using Pacilus bacteria as a host, utilizing the high expression mechanism of thermostable β-galactosidase in Bacillus subtilis. We discovered that the derived promoter has strong promoter activity,
This is based on the elucidation of its DNA structure.

本発明により目的ポリペプチドの発現に好適なパシルス
属細菌に於ける発現ベクターの作製を可能(ニジたもの
である。
According to the present invention, it is possible to construct an expression vector in a Pacillus bacterium suitable for expressing a target polypeptide.

(発明の構成) 本発明は好熱菌パシルス・ステアロサーモフィルス由来
のプロモーターを含む式〔I〕で示されるDNA、その
DNAを組込んだ組換体DNAおよびそれらを含む微生
物(=関するものである。
(Structure of the Invention) The present invention relates to a DNA represented by the formula [I] containing a promoter derived from the thermophilic bacterium Pacillus stearothermophilus, a recombinant DNA incorporating the DNA, and a microorganism containing them (=related). be.

5’  GGCCTATATATTTGGTTGTTT
TTAA3’  CCGGATATATAAACCAA
CAAAAATTTTAAAAAATATATATTT
ATTTAGTAAATTTTTTATATATAAA
TAAATCATAAATATTGTTGTTGACA
AATACTAATTTATAACAACAACTGT
TTATGATTA、TTTTAACTTAAT’l’
TATAATTAAACTAAAATTGAATTAA
ATATTAATTTGバシルス・ステアロサーモフィ
ルスから単離したbga B遺伝子は大腸菌プラスミド
pH01,−G2(特願昭58−171077号)ある
いは枯草菌プラスミド田G5(特願昭59−20296
5号)にクローン化されている。
5' GGCCTATATATTTGGTTGTTT
TTAA3' CCGGATATATAAACCAA
CAAAAATTTTTAAAAAAATATATATTTT
ATTTAGTAAAATTTTTTATATATAAAA
TAAATCATAAAATATTGTTGTTGACA
AATACTAATTTATAACAACAACTGT
TTATGATTA, TTTTAACTTAAT'l'
TATAATTAAAACTAAAATTGAATTAA
ATATTAATTTG The bga B gene isolated from Bacillus stearothermophilus was isolated from Escherichia coli plasmids pH01, -G2 (Japanese Patent Application No. 171077/1983) or Bacillus subtilis plasmid G5 (Japanese Patent Application No. 59/20296).
No. 5).

このbga f3遺伝子からのbga Bプロモーター
領域を含むDNAの単離はプラスミドpH01,pH0
2あるいはpH05を制限酵素で切断することC二より
行うことが出来る。
Isolation of DNA containing the bga B promoter region from this bga f3 gene was carried out using plasmids pH01 and pH0.
This can be done by cleaving C2 or pH05 with a restriction enzyme.

そのDNAを組込んだ組換体DNAの調製は。Preparation of recombinant DNA incorporating that DNA.

単離したDNAと制限酵素で切断したベクターDNAと
をT4DNAリガーゼで連結することにより行うことが
出来る。
This can be carried out by ligating the isolated DNA and vector DNA cut with a restriction enzyme using T4 DNA ligase.

ここで用いるベクターDNAとしてはpUB 110゜
1)E194. pC194,pBD9. pTP4.
 pPL603.  等のパシルス属細菌で複製可能な
プラスミドが好適である。
The vector DNA used here is pUB110°1)E194. pC194, pBD9. pTP4.
pPL603. Plasmids that can be replicated in Pacillus bacteria such as plasmids are preferred.

上記方法で得られた組換体DNAのパシルス属細菌への
導入はプロトプラスト形質転換法〔モレキュラー・アン
ド・ゼネラル・ゼネテイックス(Molecular 
and General Genetics)、第16
8巻。
The recombinant DNA obtained by the above method was introduced into Pacilus bacteria using the protoplast transformation method [Molecular & General Genetics
and General Genetics), No. 16
Volume 8.

111頁、 1979年、)C二より行うことが出来る
111, 1979) C2.

組換体DNA(即ち、bgaB遺伝子のプロモーターを
含むDNAを組込んだベクターDNA)を有する菌株の
選択方法は、当該組換体DNAの調製C:使用した制限
酵素やベクターDNAの種類によっても異なるが2例え
ば制限酵素としてEco RIとPst lを用いベク
ターとしてpPL603を用いた場合には、このbga
 BプロモーターC:より下流のcat−86遺伝子が
発現するのでクロラムフェニコールとカナマイシンを含
むDM3寒天培地C:生育可能なコロニーとして選択出
来る。
The method for selecting a strain having recombinant DNA (i.e., vector DNA incorporating DNA containing the bgaB gene promoter) is as follows: Preparation of the recombinant DNA (C): Although it varies depending on the restriction enzyme used and the type of vector DNA, For example, if Eco RI and Pst I are used as restriction enzymes and pPL603 is used as a vector, this bga
B Promoter C: Since the downstream cat-86 gene is expressed, DM3 agar medium containing chloramphenicol and kanamycin C: Can be selected as a viable colony.

なおりM3寒天培地は次の8溶液を別、滅菌後混合して
調製する。
Naori M3 agar medium is prepared by separately mixing the following 8 solutions after sterilization.

1)  4チ寒天          200−2) 
IMコハク酸ナトリウム(pH7,3)     50
011t13)5チカザミノ酸        100
−4)10%酵母エキス        50−3.5
係リン酸2カリウム+   、。。d5)1.5チリン
酸lカリウム 6)20チグルコース        251L17)
  IMMgcZ、                
20y8)2チ牛血清アルブミン      5d次い
で、上記方法で得られた組換体DNA菌株より組換体D
NAをアルカリ抽出法〔ニークレイツク・アシッド・リ
サーチ(Nucleic Ac1dsResearch
 )第7巻、 1513頁、 1979年、〕(二よっ
て単離し、該DNAが組込まれていることをジデオキシ
法〔チイx y ス(5cience ) 第214巻
、 1205頁。
1) 4chi agar 200-2)
IM sodium succinate (pH 7,3) 50
011t13)5 ticazamino acid 100
-4) 10% yeast extract 50-3.5
Dipotassium phosphate+. . d5) 1.5 potassium typhosphate 6) 20 tyglucose 251L17)
IMMgcZ,
20y8) 2C Bovine serum albumin 5dNext, recombinant D was obtained from the recombinant DNA strain obtained by the above method.
Alkaline extraction method of NA [Nucleic Acid Research
) Vol. 7, p. 1513, 1979] (2), and the incorporation of the DNA was determined by the dideoxy method [5science, Vol. 214, p. 1205.

1981年、〕 で塩基配列を決定し確認する。In 1981, the base sequence was determined and confirmed.

次に9本発明の詳細な説明するため実施例を示す。Next, 9 Examples will be shown to explain the present invention in detail.

なお、以下)二示す実施例は、DNA供与体としてbg
a B遺伝子をクローン化したプラスミドpH02を保
持する大腸菌エシェリヒア・コ!J 294−43(p
H02)(微工研菌寄第7233号)を、ベクターDN
AとしてpPL603 (ジャーナル・オブ・バタテリ
オロジ−(Journal of Bacteriol
ogy)第146巻、  1162頁、  1981年
、〕を、宿主微生物としてパシルス・ズブチリスRM1
25(モレキュラー・アンド・ゼネラル・ゼネティック
ス第152巻。
In addition, in the following two examples, bg was used as the DNA donor.
a Escherichia coli carrying plasmid pH02 in which the B gene has been cloned! J 294-43 (p.
H02) (Feikoken Bibori No. 7233), vector DN
pPL603 (Journal of Bacteriology) as A.
146, p. 1162, 1981] was used as a host microorganism, Pacillus subtilis RM1.
25 (Molecular and General Genetics Vol. 152.

65頁、  1977年、)〔本微生物はオハイオ州立
大学。
p. 65, 1977) [This microorganism was produced by The Ohio State University.

パシルス・ゼネティック拳ストック・セン9−(Bac
illus Genetic 5tock Cente
r) (:パシルス・ズブチリスI A 253として
保存されており、誰でも入手可能である。〕 をそれぞれ利用して行った例である。
Pasir Genetic Fist Stock Sen 9-(Bac
illus Genetic 5tock Cente
r) (: Pasillus subtilis IA 253, and is available to anyone).

実施例1.(bga B遺伝子のプロモーターを含むD
NAの単離) エシェリヒア・コリ294−43 (pH02)をM9
培地(Na、 HPO45,8ji/l、 KH2PO
23l/l 。
Example 1. (D containing the bga B gene promoter
Isolation of NA) Escherichia coli 294-43 (pH 02) was
Medium (Na, HPO45, 8ji/l, KH2PO
23l/l.

NaCL 59/l、 NH4cz 1 i/L、 C
aC/411m+5;’/’4Mg5Oa 95′It
9/4 Fect31,6iy/4  カザミノ酸51
1/l、  グルコース4.y/z) 1501111
中、37℃で培養液の600 nmの吸光度が0.6−
1.0になるまで培養後、200μI/!Klのクロラ
ムフェニコールヲ添加して一夜培養を続けた。菌体を集
洗菌後、21v/dのりゾテームを含む25 mM T
ris −HCL (pH8,0)、  50mMグ/
I/ニア−、C,10mMEDTA、15m(:懸濁し
、0℃で30分間放置後、  0.2NNaOH。
NaCL 59/l, NH4cz 1 i/L, C
aC/411m+5;'/'4Mg5Oa 95'It
9/4 Fect31,6iy/4 Casamino acid 51
1/l, glucose4. y/z) 1501111
The absorbance at 600 nm of the culture solution at 37°C was 0.6-
After culturing until it reaches 1.0, 200μI/! Chloramphenicol (Kl) was added and the culture was continued overnight. After collecting and washing the bacterial cells, 25 mM T containing 21 v/d Norizotame was added.
ris-HCL (pH 8,0), 50mM g/
I/Nia-, C, 10mM EDTA, 15M (: Suspend and leave at 0°C for 30 minutes, then add 0.2N NaOH.

ILsSDS(ラウリル硫酸f−) !J クム)30
mヲ加え溶菌させ、0℃で5分間放置した。次いで3M
酢酸ナトリウム(關4.8 ) 22.5友lを加え、
0℃で1時間放置後、遠心分離(8,00Orpm、 
20分)して上溝を得た。上清C二2.5倍量のエタノ
ールを加え、DNAを沈殿させた後、5友lのlQmM
Tris −HCL (pH7,5) 、  1 mM
 EDTA(以下TE緩衝液と称す)に溶かした。この
DNA溶液を工tジクムブロマイドー塩化セシクム平衡
密度勾配遠心にかけ、pH02プラスミド500μsを
得た。
ILsSDS (lauryl sulfate f-)! J Kum) 30
ml was added to lyse the bacteria, and the mixture was left at 0°C for 5 minutes. Then 3M
Add 22.5 ml of sodium acetate (4.8 liters),
After standing at 0°C for 1 hour, centrifugation (8,00 rpm,
20 minutes) to obtain a superior groove. Add 2.5 times the amount of ethanol to supernatant C to precipitate the DNA, then add 5 liters of 1QmM
Tris-HCL (pH 7,5), 1 mM
It was dissolved in EDTA (hereinafter referred to as TE buffer). This DNA solution was subjected to dicum bromide-sesicum chloride equilibrium density gradient centrifugation to obtain a pH02 plasmid of 500 μs.

bga B遺伝子のプOモーターを含むDNA (10
7bp (D Hae [1−Alu (断片)を単離
するため、100μIのpHG2に対し200Uの、H
indl[と1200(7)C1aIを加え、  10
mM Tris −HCt (pH18,0)、  1
0 mMMgCt、、50mMNaCt、1mMジ?、
tスレイ)−ル(7)反応液320μを中で、37℃で
4時間処理した後。
DNA containing the pO motor of the bga B gene (10
To isolate the 7 bp (D Hae [1-Alu (fragment)), 200 U of H
add indl[ and 1200(7)C1aI, 10
mM Tris-HCt (pH 18,0), 1
0mM MgCt, 50mM NaCt, 1mM di? ,
After treatment at 37° C. for 4 hours in 320μ of the reaction solution (7).

4%ポリアクリルアミドゲル電気泳動(二より分画し、
  975bl)のl(ind 1l−−1断片ヲ回収
り、り。
4% polyacrylamide gel electrophoresis (two fractions,
975 bl) was recovered.

(13μI几 975bpの)(ind Ill −C1a l断片1
3μ、9+二対し、36UのHae[lを加え、  1
0 mM Tris −HCt (pH7,5) 。
(13 μl 975 bp) (ind Ill-C1a I fragment 1
3μ, 9+2 pairs, add 36U Hae[l, 1
0 mM Tris-HCt (pH 7,5).

10mMMgct2,50mMNact、1mMジテオ
スレイトールの反応液50g中で37℃で3時間処理し
た後、70’Cで10分間加熱してHae[lを失活さ
せた。
After treatment at 37° C. for 3 hours in 50 g of a reaction solution containing 10 mM Mgct2, 50 mM Nact, and 1 mM diteothreitol, Hae[l was inactivated by heating at 70° C. for 10 minutes.

T4ポリヌクレオチドキナーゼで5′末端をリン酸化し
たEC0RIリンカ−pGGAA’I’Tcc (宝酒
造製) 250pmo(を加え、  66 mM Tr
is −Hct(pH7,5) 、  10mM Mg
Ctz、  10mM 9 f オスL/ イ)  /
I/、1mMATPの反応液100μを中で125Uの
T4DNA!JガーゼC二より15℃で16時間反応さ
せた。
EC0RI linker-pGGAA'I'Tcc (manufactured by Takara Shuzo) whose 5' end was phosphorylated with T4 polynucleotide kinase (250 pmo) was added, and 66 mM Tr
is-Hct (pH 7,5), 10mM Mg
Ctz, 10mM 9f male L/I)/
I/, 125U of T4 DNA in 100μ of 1mM ATP reaction solution! The reaction was carried out using J gauze C2 at 15°C for 16 hours.

65℃で20分間加熱してT4DNA!Jガーゼを失活
させた後、4μtのIMNaCzを加えた反応液104
μを中、60UのEco Riと48 U (D Al
u ■テ37℃、4時間処理した。
Heat at 65°C for 20 minutes to create T4DNA! After inactivating J gauze, 4 μt of IMNaCz was added to reaction solution 104.
μ in medium, 60U Eco Ri and 48U (D Al
u ■Te Processed at 37°C for 4 hours.

70℃、 10分間加熱し、 EcoRlとAlu I
を失活させた後これ(ニーT4ボリヌクレオデドキナー
ゼで5′末端をリン酸化したPsti9ンカー pGC
TGCAGC(宝酒造製) 200pmolを加え、6
6mM Tris−HCt(pkl 7.5 ) 、 
10 mM MgCt、、 10 mMジテオスレイト
ール、  1 mM A T Pの反応液200μを中
で、  150UのT4DNAリガーゼ(二より15℃
で16時間反応させた。
Heat at 70°C for 10 minutes to combine EcoRl and AluI.
After inactivating this pGC
Add 200 pmol of TGCAGC (manufactured by Takara Shuzo) and add 6
6mM Tris-HCt (pkl 7.5),
Add 150 U of T4 DNA ligase (150 U of
The reaction was carried out for 16 hours.

65℃、20分間加熱してT4DNAリガーゼを失活さ
せた後20μtのIMNactを加えた反応液210μ
を中、60UのPst lで37℃、3時間処理した。
After heating at 65°C for 20 minutes to inactivate T4 DNA ligase, 210μ of the reaction solution was added with 20μt of IMNact.
was treated with 60 U of Pstl at 37° C. for 3 hours.

このDNA溶液を5チポリアクリルアミドゲル電気泳動
C二より分画し、  119bpのEcoRl −Ps
t l断片を回収した。(1,5μg)。
This DNA solution was fractionated by 5 polyacrylamide gel electrophoresis C2, and 119bp EcoRl-Ps
The tl fragment was collected. (1.5 μg).

実施例2.(ベクターDNAの調製と切断)カナマイシ
ン耐性を有するp PL603のDNAを下記のよう(
ニジて調製した。
Example 2. (Preparation and cutting of vector DNA) DNA of pPL603 having kanamycin resistance was prepared as follows (
Prepared by stirring.

p PL 603をプラスミドとして持つ公知の枯草菌
、パシルス・ズブチリスIE31 [オへイオ州立大学
、バシルス・ゼネティック・スl−ツク・セy 9−(
Bacillus 0enetic 5tock Ce
nter )より入手〕をL培地(トリプトン1チ、酵
母エキス0.5t4 、  Na C10,5% + 
 グル:7−ス0.2%、 pH7,0) 50佃ノ中
、37℃で培養液の5QQ nmの吸光度が2〜3(=
なるまで振とう培養し、菌体を集洗菌後、2〜/R1ノ
リゾテームを含む25 mM Tris −HCt(p
H8,0)。
A known Bacillus subtilis, Pacilus subtilis IE31, carrying pPL 603 as a plasmid [Ohio State University, Bacillus Genetic Science Department 9-(
Bacillus 0enetic 5tock Ce
(obtained from Nter)] was mixed with L medium (1 g tryptone, 0.5 t4 yeast extract, 10.5% Na C +
Glue: 7-su 0.2%, pH 7.0) The absorbance of the culture solution at 5QQ nm was 2-3 (=
After culturing with shaking until the bacterial cells were collected and washed, 25 mM Tris-HCt (p
H8,0).

50mMグ/l/:7−ス、  10mMEDTA50
WtJ!i:l−懸濁し。
50mM g/l/:7-su, 10mM EDTA50
WtJ! i:l-suspended.

37℃で30分間放置する。0.2MNaOH,1l 
S D 8100m/を加え溶菌させ、0℃で5分間放
置した。
Leave at 37°C for 30 minutes. 0.2M NaOH, 1l
SD 8100m/ was added to lyse the bacteria, and the mixture was left at 0°C for 5 minutes.

次いで3M酢酸ナトリウム(pH4,8) 75m/を
加え。
Then, 75ml of 3M sodium acetate (pH 4,8) was added.

0℃で1時間放置後、遠心分離(8,00Orpm、 
20分)して上清を得た。上清(二2.5倍量のエタノ
ールを加え、DNAを沈殿させた後、5dのTE緩衝液
に溶かした。このDNA溶液を工tジウムプロマイド・
塩化セシウム平衡密度勾配遠心にかけ、  pPL 6
03プラスミドD N A 50μgを得た。
After standing at 0°C for 1 hour, centrifugation (8,00 rpm,
20 minutes) to obtain a supernatant. After adding 2.5 times the volume of ethanol to the supernatant (2) to precipitate the DNA, it was dissolved in 5d TE buffer.
Cesium chloride equilibrium density gradient centrifugation, pPL 6
50 μg of 03 plasmid DNA was obtained.

ベクターDNAを切断するため、  pPL 6032
.2μg(二対してIOUのEcoRlと5UのPst
 lを加え。
pPL 6032 to cut the vector DNA
.. 2μg (2 vs. IOU of EcoRl and 5U of Pst
Add l.

50 mM Tris −H(1(pH7,5) 、 
10 mM MgC4、100mMNa CL、 l 
mMジチオスレイトールの反応液25μを中で37℃、
2時間反応を行った。70℃、10分間加熱してEco
RIとPst lを失活させた。
50 mM Tris-H (1 (pH 7,5),
10mM MgC4, 100mM NaCL, l
Add 25μ of the reaction solution of mM dithiothreitol at 37°C.
The reaction was carried out for 2 hours. Heat at 70℃ for 10 minutes to make it Eco
RI and Pstl were inactivated.

実施例3.(bga Bプロモーターを含むDNA断片
とベクターDNAの連結) 実施例1で得たDNA断片0.5μ9と実施例2で得た
ベクターD N A 0.51t/iを55 mM T
ris −Hct(pH7,5)、 10mMMgCz
、、 10mM シf 、t /Cv イ)−,11/
、  1 mM A T P (7)反応液35pL中
で50UのT4DNA!Jガーゼにより15℃、16時
間反応させた。
Example 3. (Legation of DNA fragment containing bga B promoter and vector DNA) 0.5 μ9 of the DNA fragment obtained in Example 1 and 0.51 t/i of the vector DNA obtained in Example 2 were combined at 55 mM T.
ris-Hct (pH 7,5), 10mM MgCz
,, 10mM Sif,t/Cv i)-,11/
, 1 mM ATP (7) 50 U of T4 DNA in 35 pL of reaction solution! The reaction was carried out using J gauze at 15°C for 16 hours.

ここまでの工程の概略は第1図C:示した。An outline of the steps up to this point is shown in Figure 1C.

実施例4.(組換体DNAによる枯草菌の形質転換) バンルス・ズブテリ、cRM125をPenassay
 broth(肉エキス0.15%、酵母エキス0.1
5%、ペプト10.5%、グ/I/ コース0.1 %
 、  NactO,3% 、  リン酸2カリウム0
.37%、  リン酸1カリクム0.13L。
Example 4. (Transformation of Bacillus subtilis with recombinant DNA) Penassay Banrus subtilis, cRM125
broth (meat extract 0.15%, yeast extract 0.1
5%, Pepto 10.5%, G/I/Course 0.1%
, NactO, 3%, dipotassium phosphate 0
.. 37%, 1 potassium phosphate 0.13L.

pi(7,0) 20ゴ中37℃で、570面の吸光度
が0.8−1.OC二なるまで振とう培養し、集菌する
。2 w/ldのリゾチームを含むSMMP溶液(2倍
濃度の8MM溶液と4倍濃度のPenassay br
othを等量2合した溶液) 2.5mA!≦二懸濁し
、37℃で2時間、おだやか(:振とうしながらプロト
プラストを調製する。
pi(7,0) At 37°C in 20g, the absorbance of the 570 plane is 0.8-1. Culture with shaking until OC2 is reached and collect bacteria. SMMP solution containing 2 w/ld lysozyme (2x 8MM solution and 4x Penassay br
A solution of two equal amounts of oth) 2.5 mA! Prepare protoplasts by suspending and gently shaking at 37°C for 2 hours.

プロトプラストを遠心分離(4,00Orpm、 15
分)で集め8MMP溶液で洗浄後、再度遠心分離し。
Centrifuge the protoplasts (4,00 Orpm, 15
After washing with 8MMP solution, centrifugation was performed again.

2′R1のSMNP溶液(二懸濁する。2'R1 SMNP solution (suspend twice.

なお、8MM溶液は0.5M i/ !糖、20mMマ
レイン酸(pH6,5) 、  20mM MgCZ、
 ヨGJ 7’Z 611合液である。
In addition, 8MM solution is 0.5M i/! Sugar, 20mM maleic acid (pH 6,5), 20mM MgCZ,
This is a mixture of YoGJ7'Z611.

実施例3で得たDNA溶液35μtと2倍濃度の8MM
溶液35μtの混合液に対し、このプロトプラスト懸濁
液0.51+7.および1.5dの40チボリエテレン
グリコール溶液(10017中(:ポリエチレングリコ
ール6000を40.!i’、  2倍濃度の8MM溶
液50コを含む)を加え、2分間放置後、  5+jの
SMMP溶液を加え、プロトプラストを遠心分離で回収
した。このプロトプラストを1−のSMMP溶液(二懸
濁し、30℃で1.5時間振とう培養後、カナマイシン
(1xtg/d )およびクロラムフェニコール(10
μg/d)DM3再生用寒天培地に塗布した。37℃で
2日間培養すると組換体DNAを保持する枯草菌はカナ
マイシン、クロラムフェニコールの両抗生物質(二耐性
なコロニーとして取得出来る。
35μt of DNA solution obtained in Example 3 and 8MM at double concentration
This protoplast suspension was mixed with 35 μt of solution at 0.51+7. and 1.5d of 40 tiboethylene glycol solution (in 10017 (: 40.!i' of polyethylene glycol 6000, containing 50 parts of 8MM solution at twice the concentration), and after standing for 2 minutes, add 5+j of SMMP solution. In addition, the protoplasts were collected by centrifugation. The protoplasts were suspended in 1-SMMP solution (2), cultured with shaking at 30°C for 1.5 hours, and then incubated with kanamycin (1xtg/d) and chloramphenicol (10
μg/d) was applied to an agar medium for DM3 regeneration. When cultured at 37°C for 2 days, Bacillus subtilis retaining the recombinant DNA can be obtained as a colony resistant to both kanamycin and chloramphenicol antibiotics.

このようにして得た新規な枯草菌はパシルス・ズブチリ
スRM125 (pTF 6 )と命名した。
The novel Bacillus subtilis thus obtained was named Pacillus subtilis RM125 (pTF 6 ).

なお、このバシルス・ズブチリスRM125(pTF6
)の菌学的性質はカナマイシン耐性、クロラムフェニコ
ール耐性を示す以外は普通の枯草菌の性質と同一である
In addition, this Bacillus subtilis RM125 (pTF6
) has the same mycological properties as ordinary Bacillus subtilis, except that it exhibits resistance to kanamycin and chloramphenicol.

実施例5.(組換体プラスミドの構造解析)バシルス・
ズブチリスRM 125 (pTF 6 )からの組換
体プラスミドの調製は実施例2に記載の方法で行った。
Example 5. (Structural analysis of recombinant plasmids) Bacillus
A recombinant plasmid from S. subtilis RM 125 (pTF 6 ) was prepared by the method described in Example 2.

1)TF62μg≦二EcoR15Uとpst(5Uを
加え。
1) Add 62μg of TF≦2 EcoR15U and pst (5U).

50 mM ’l”ris−HCt(pH7,5) 、
  10 mM Mgct*、 100 mMNaCt
、 1mMジテオスレイトールの反応液50μを中で3
7℃、2時間処理して生じた2種のDNA断片の大きさ
を5チポリアクリルアミドゲル電気泳動および1%アガ
ロースゲル電気泳動で測定すると4600 bpと11
9bpであった。
50 mM 'l'ris-HCt (pH 7,5),
10mM Mgct*, 100mM NaCt
, 50μ of 1mM diteothreitol reaction solution was added to
The sizes of the two types of DNA fragments generated after treatment at 7°C for 2 hours were measured by 5-tuply polyacrylamide gel electrophoresis and 1% agarose gel electrophoresis, and they were 4600 bp and 11 bp.
It was 9 bp.

次(二、この119bpのDNA断片の塩基配列をジデ
オキシ法で決定した結果、  bgaBプロモーターを
含む107bi)のHae 1ll−Alu l断片の
末端にEco RIリンカ−、Pstlリンカ−の連結
した構造であることが確認できた。
Second, as a result of determining the base sequence of this 119 bp DNA fragment by the dideoxy method, it has a structure in which an Eco RI linker and a Pstl linker are connected to the end of the Hae 1ll-Alu I fragment (107 bp including the bgaB promoter). This was confirmed.

(発明の効果) 本発明のbga Bプロモーターを含むDNAがパシル
ス属細菌C二おいて高い発現効率を有することを試験例
C二より説明する。
(Effects of the Invention) It will be explained from Test Example C2 that the DNA containing the bga B promoter of the present invention has high expression efficiency in Pacillus bacteria C2.

試験例 [bga Bプロモーターにより発現したca
t−→6遺伝子産物(クロラムフェニコールア セチルトランスフェラーゼ)生産量の 比較〕 パシルス・ズブチリスRM 125 (pTF 6 )
を5μg/コクロラムフェニコール及び1%グルコース
を含むPenassay broth 5Qm中で37
℃、20時間娠とう培養し、集菌後0.1 M Tri
s −HCl (pH7,8) 5 RIC:懸濁する
。超音波処理後、遠心分離(15000rpm、 15
分)して得た上清を細胞抽出液とした。
Test example [ca expressed by bga B promoter
Comparison of t-→6 gene product (chloramphenicol acetyltransferase) production] Pacillus subtilis RM 125 (pTF 6)
37 in Penassay broth 5Qm containing 5 μg/cochloramphenicol and 1% glucose.
℃, gestation culture for 20 hours, and after bacterial collection, 0.1 M Tri
s-HCl (pH 7,8) 5 RIC: Suspend. After ultrasonication, centrifugation (15000 rpm, 15
The supernatant obtained was used as a cell extract.

この細胞抽出液のクロラムフェニコールアセチルトラン
スフェラーゼ(以下CATという)活性をシャツ(W、
 V、 Shaw )の方法〔メソッド・イy a x
 yテモロジイ(Methods in Engymo
logy)第43巻737頁、 1975年、〕で測定
すると17U/■蛋白であった。
The chloramphenicol acetyltransferase (hereinafter referred to as CAT) activity of this cell extract was measured using a shirt (W).
V, Shaw) method
Methods in Engymo
43, p. 737, 1975), it was 17 U/■ protein.

pPL 603を保持するパシルス・ズーIf−9スR
M125を同様な方法で培養して得た細胞抽出液(7)
CAT活性)10.052 U/1に9蛋白であったの
で。
Pasirus Zoo If-9S R carrying pPL 603
Cell extract obtained by culturing M125 in a similar manner (7)
CAT activity) 9 proteins in 10.052 U/1.

bga Bプロモーターを導入することによりCAT生
産量は約300倍上昇したこと(二なる。
By introducing the bga B promoter, CAT production increased approximately 300 times (second result).

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の組換体DNApTF6の製造法のフロ
ーチャートを示す。図中E Id、 BcoRl 。 CはC1al、HはHindlll、 PはPstl、
BはBamHl。 BgはBgl Itの制限部位をそれぞれ示す。 Tcはテトラチイクリン耐性遺伝子、 Kmはカナマイ
ンン耐性遺伝子、  cat−86はクロラムフェニコ
ール耐性遺伝子を示す。
FIG. 1 shows a flowchart of the method for producing recombinant DNApTF6 of the present invention. In the figure, E Id, BcoRl. C is C1al, H is Hindll, P is Pstl,
B is BamHl. Bg indicates the restriction site of Bgl It, respectively. Tc represents a tetrathiicline resistance gene, Km represents a kanamain resistance gene, and cat-86 represents a chloramphenicol resistance gene.

Claims (3)

【特許請求の範囲】[Claims] (1)好熱菌バシルス、ステアロサーモフィルス由来の
プロモーター領域を含む式〔 I 〕で示されるDNA。 ▲数式、化学式、表等があります▼・・・〔 I 〕
(1) DNA represented by formula [I] containing a promoter region derived from thermophilic bacteria Bacillus and Stearothermophilus. ▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・〔I〕
(2)式〔 I 〕で示されるDNAを組込んだ組換体D
NA。 ▲数式、化学式、表等があります▼・・・〔 I 〕
(2) Recombinant D incorporating the DNA represented by formula [I]
N.A. ▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・〔I〕
(3)式〔 I 〕で示されるDNAを組込んだ組換体D
NAを含む微生物。 ▲数式、化学式、表等があります▼・・・〔 I 〕
(3) Recombinant D incorporating the DNA represented by formula [I]
Microorganisms containing NA. ▲There are mathematical formulas, chemical formulas, tables, etc.▼・・・〔I〕
JP60110565A 1984-09-29 1985-05-24 Dna, recombinant dna and microorganism containing same Pending JPS61268183A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP60110565A JPS61268183A (en) 1985-05-24 1985-05-24 Dna, recombinant dna and microorganism containing same
US06/780,842 US4861718A (en) 1984-09-29 1985-09-27 Gene coding for thermostable beta-galactosidase, bacillus subtilis having the gene, enzyme coded by the gene and a process for the production thereof
DE198585112245T DE176971T1 (en) 1984-09-29 1985-09-27 FOR A THERMOSTABLE BETA GALACTOSIDASE, ENCODING GENE, BACILLUS SUBTILIS CONTAINING THIS GENE, ENZYME ENCODED BY THIS GENE AND METHOD FOR THE PRODUCTION THEREOF.
EP85112245A EP0176971A3 (en) 1984-09-29 1985-09-27 Gene coding for thermostable beta-galactosidase, bacillus subtilis having the gene, enzyme coded by the gene and a process for the production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60110565A JPS61268183A (en) 1985-05-24 1985-05-24 Dna, recombinant dna and microorganism containing same

Publications (1)

Publication Number Publication Date
JPS61268183A true JPS61268183A (en) 1986-11-27

Family

ID=14539052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60110565A Pending JPS61268183A (en) 1984-09-29 1985-05-24 Dna, recombinant dna and microorganism containing same

Country Status (1)

Country Link
JP (1) JPS61268183A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01215280A (en) * 1988-02-23 1989-08-29 Showa Denko Kk Improvement of microorganism
EP0955368A2 (en) 1998-03-18 1999-11-10 Ajinomoto Co., Ltd. L-glutamic acid-producing bacterium and method for producing l-glutamic acid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5519092A (en) * 1978-06-08 1980-02-09 Harvard College Selected protein producing method
JPS57132895A (en) * 1980-12-31 1982-08-17 Parubua Irutsuka Production of rearranged dna molecule and protein

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5519092A (en) * 1978-06-08 1980-02-09 Harvard College Selected protein producing method
JPS57132895A (en) * 1980-12-31 1982-08-17 Parubua Irutsuka Production of rearranged dna molecule and protein

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01215280A (en) * 1988-02-23 1989-08-29 Showa Denko Kk Improvement of microorganism
JP2708168B2 (en) * 1988-02-23 1998-02-04 昭和電工株式会社 Microbial improvement
EP0955368A2 (en) 1998-03-18 1999-11-10 Ajinomoto Co., Ltd. L-glutamic acid-producing bacterium and method for producing l-glutamic acid

Similar Documents

Publication Publication Date Title
JPH0755153B2 (en) Recombinant DNA molecule and method for producing the same
EP0057976B1 (en) a process for cloning the gene coding for a thermostable alpha-amylase into escherichia coli and bacillus subtilis
JPH0669376B2 (en) Ultra-high prokaryotic expression system
WO1984000774A1 (en) Staphylococcal protein a coding gene (dna) fragment comprising a signal dna sequence, a process for its preparation and a microorganism transformed therewith
Haijema et al. The C terminus of the AddA subunit of the Bacillus subtilis ATP-dependent DNase is required for the ATP-dependent exonuclease activity but not for the helicase activity
JPS61268183A (en) Dna, recombinant dna and microorganism containing same
JPS592689A (en) Preparation of novel replicon having high manifestation ability of gene
JP2948265B2 (en) DNA fragment encoding nucleoside phosphorylase
JPH0249590A (en) Gene coding heat-resistant tryptophan synthetase and use thereof
EP0186631B1 (en) Psm112 plasmid vector for expression in bacillus subtilis
JP3014717B2 (en) DNA fragment encoding purine nucleoside phosphorylase
JPS6255089A (en) Dna fragment containing phosphoenolpyruvic acid carboxylase-producing gene
JP2615090B2 (en) Plasmids and Escherichia coli transformed therewith
JP2833793B2 (en) Plasmid encoding heparinase, heparinase-producing strain carrying this plasmid, and method for producing heparinase
JP2500312B2 (en) Human growth hormone production method
JP2524794B2 (en) Complex plasmid vector
JPS61205484A (en) Novel plasmid
JPH0679556B2 (en) Plasmid
JPH0314434B2 (en)
JPS62143685A (en) Novel heat-resistant beta-galactosidase and gene coding same
FI120155B (en) Process and system for increased production of commercially important exoproteins in gram-positive bacteria
JPH0139753B2 (en)
JPH0314435B2 (en)
JPS6181788A (en) Novel bacillus subtilis containing thermostable beta-galactosidase and production of thermostable beta-galactosidase
JP2681634B2 (en) New bacterial strain with enhanced thermostable liquefied amylase production capacity